Skip to main content
OpenTrials
Completed

NCT Number: NCT06040333

Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dysfunctional Voiding

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Haliç University

Istanbul, Turkey (Türkiye)

About this study

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. This experimental study was conducted with patients who applied to UroKlinik in Istanbul between March 2021 and June 2023 and were diagnosed with dysfunctional voiding. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form and Uroflowmetry test were applied to all participants before and at week 6.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having been diagnosed with dysfunctional voiding,
  • Being between the ages of 18-75,
  • Not having a neurogenic bladder
  • Not having a urinary tract infection
  • Not having an obstacle to exercise,
  • Accepting and signing the Approval Form,
  • Not having undergone surgery in the last 6 months,

Exclusion criteria

  • Not being cooperative
  • Not being able to participate in the treatment,
  • The use of drugs that will affect urination

Treatment and study plan

Exercise

Other

Dynamic Neuromuscular Stabilisation Exercise

Standard therapy

Other

Patient education, massage, diaphragmatic breathing, kegel exercise

Primary outcomes

  1. Uroflowmetry - Maximum flow rate (Qmax)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *Qmax (mL/s): Qmax is the fastest stream measured in mL/s.

  2. Uroflowmetry - Average flow rate (Qave)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *Qave (mL/s): Qave is the average stream measured in mL/s.

  3. Uroflowmetry - Corrected maximum flow rate (cQmax)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *cQmax (mL/s/√ mL): cQmax is the precise assessment of fastest stream, especially at high volumes. Is it estimated Qmax/√ VV.

  4. Uroflowmetry - Flow time (FT)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *FT (s): FT is the time over which measurable flow actually occurs.

  5. Uroflowmetry - Voiding volume (VV)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *VV (ml): VV indicates the amount of voiding.

  6. Uroflowmetry - Residual urine (RU)

    Time frame: at the baseline and at week 6.

    Uroflowmetry gives information about urine flow rate and voiding pattern.

    *RU (ml): RU is the amount of urine that is left behind in the bladder after you are done urinating.

  7. Dysfunctional Voiding and Incontinence Symptom Score

    Time frame: at the baseline and at week 6.

    It gives information about voiding and incontinence symptoms. The questionnaire contains fourteen questions about symptoms and quality of life. The total score ranges from 0 to 35 and a score above 8.5 indicates abnormalities.

  8. Short Form 36

    Time frame: at the baseline and at week 6.

    It gives information about health related quality of life. The total score of the scale ranges from 0 to 100, and a high score indicates a high quality of life.

Sponsors and collaborators

Lead sponsor

Halic University

Other

Registry information

Official study title

The Effect of Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding : A Randomized Clinical Trial

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Sep 15, 2023
Registry last updated
Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.